2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

Paper Details

Abstracts, authors, affiliations, and disclosures.

SESSION

904. Outcomes Research: Hemoglobinopathies: Poster III

Program: Poster Abstract Session
Monday, December 14, 2026
06:00 p.m. - 08:00 p.m.
MCCNO - Hall F
Access, Representation, Population Health, Technology and Procedures, Profiling, Treatment Considerations, Supportive Care, Biological Therapies, Gene Therapy, Women’s Health, Adverse Events, Clinical Practice (Health Services and Quality), Clinical Guidelines, Health Economics, Patient Safety, Practice Models, Quality Improvement, Quality of Care, Systems-Based Hematology, Diseases, Genetic Disorders, Hemoglobinopathies, Sickle Cell Disease, Thalassemia, Immunology, Immunodeficiency, Research, Clinical Research, Epidemiology, Health Outcomes Research, Health Disparities Research, Patient-Reported Outcomes, Real-World Evidence, Registries, Study Population, Human, Adult, Pediatric, Pregnant, Young Adult
PAPER

6205 Gender-based differences in emergency department utilization by age group among individuals living with sickle cell disease

Najibah Galadanci, PhD, MBBS, MPH, Allison Plaxco, PhD, MPH2, Abdelrhman Mohammed, MD3, Suhail Muzaffar, PhD4, Nicemode William Charles, MPH5, Gerhard Hellemann, PhD6, Julie Kanter, MD7
1 University of Alabama at Birmingham, Birmingham, Alabama, United States
2 University of Alabama at Birmingham, Birmingham, Alabama, United States
3 University of Alabama at Birmingham, Birmingham, Alabama, United States
4 University of Alabama at Birmingham, Birmingham, Alabama, United States
5 University of Alabama at Birmingham, Birmingham, Alabama, United States
6 University of Alabama at Birmingham, Birmingham, Alabama, United States
7 University of Alabama at Birmingham, Birmingham, Alabama, United States

Background:
Pain is the primary reason for which people living with sickle cell disease (SCD) require acute healthcare utilization (including the emergency department (ED)). Differences in ED utilization based on age and gender remain poorly characterized. It is important to evaluate how age and gender intersect to influence ED utilization to identify populations at increased risk for acute care utilization and inform targeted strategies to improve access to comprehensive SCD care.

Methods:
We used data from the Alabama Sickle Cell Data Collection (SCDC) program (ALSTATE), a Centers for Disease Control and Prevention funded surveillance program that integrates multiple data sources to identify and understand the medical pathway of individuals with SCD. We examined annual ED utilization among clinically confirmed (level 1) and probable SCD cases (level 2) in Alabama from 2022-2024, stratified by age group (0-9, 10-19, 20-29, 30-39, 40-49, 50-59, and ≥60 years) and gender. Only persons with known gender are included in the evaluation. Outcomes included any and frequent ED utilization and number of ED visits per person. Zero-inflated Poisson and logistic regression models with random subject effects were used to account for repeated observations across years and to evaluate age-related patterns in ED utilization by gender.

Results:
There are 3,072 unique individuals in ALSTATE (with known gender) including 1,707 females and 1,365 males. Annual ED utilization demonstrated distinct age-related patterns by gender especially in the young adult population where the proportion of the cohort with any ED visits was consistently elevated for females compared to males, especially for those aged 20–29 years, where the proportion with any ED visit was 64.9% and 60.7% among females versus 53.6% and 51.7% among males in 2022 and 2024, respectively (OR 1.75, 95% CI 1.25–2.47), and among those aged 40–49 years, where the corresponding proportions were 50.0% and 42.3% for females versus 44.6% and 33.9% for males (OR 1.85, 95% CI 1.07–2.62).
Notably, females had a lower proportion of cohort with any ED utilization among age group 0-9 years old (data not shown).  

There are also gender-based differences in the overall patterns of the ED visits. For females, there is a more pronounced peak in model-predicted counts in the 20-29 and 30-39 year old age groups with 1.7 (95% CI: 1.5, 1.9) and 1.6 (1.4, 1.9) visits per person, respectively, whereas for males predicted visit counts are relatively stable from childhood through age group 40-49, with model-predicted counts ranging from 1.1 (0.9, 1.4) to 1.4 (1.2, 1.6) across these age groups. For both genders, predicted ED visit counts are lowest in the 50-59 and 60+ age groups, at 0.7 (0.6, 0.9) and 0.6 (0.4, 0.8) per person for females and 0.5 (0.4, 0.7) and 0.5 (0.3, 0.7) for males, respectively. Incidence rate ratios comparing ED visits for females vs. males show that males have higher counts in the 0-9- and 10-19-year-old age groups, and females have higher counts in each subsequent age group.

Among individuals with any ED utilization, frequent ED use (≥12 visits/year) was generally more common among males than females across age groups from 0-9 through 50-59 years; however, these differences were not statistically significant.

Conclusions:
ED utilization among those with SCD demonstrate distinct age-related patterns by gender. Females experienced the highest acute care utilization from 20-39 years of age whereas ED utilization among males was highest at ages 0-9 years and remained relatively stable through ages 40-49 years before declining in older age groups. These differences may reflect broader gender-related patterns in healthcare engagement across the lifespan, as well as reproductive health factors. Among females, menstruation related exacerbation of SCD pain and pregnancy-related complications may contribute to greater acute care needs. Conversely, previous data shows that males have lower engagement with routine healthcare during young adulthood (generally-not only in SCD) which may contribute to different acute care patterns although this was not directly assessed here. Further research examining continuity of comprehensive SCD care, reproductive health, disease severity, and other clinical and social factors is needed to understand these age- and gender-specific patterns to develop informed, targeted interventions to improve care across the lifespan for everyone living with SCD.

Najibah Galadanci, PhD, MBBS, MPH: No relevant conflicts of interest to declare.